| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/08/2007 | EP1814874A1 N-heterocyclyl phthalic acid diamides as insecticides |
| 08/08/2007 | EP1814873A2 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 08/08/2007 | EP1814866A2 Gonadotropin releasing hormone receptor antagonists |
| 08/08/2007 | EP1814864A1 Nitro indazole derivatives |
| 08/08/2007 | EP1814863A1 Indazole sulphonamide derivatives |
| 08/08/2007 | EP1814862A1 Vinylaminopyrazole derivatives as pesticides |
| 08/08/2007 | EP1814861A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 08/08/2007 | EP1814859A2 Methods for preparing indazole compounds |
| 08/08/2007 | EP1814856A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 08/08/2007 | EP1814851A2 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 08/08/2007 | EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/08/2007 | EP1814552A2 Compounds for treating protein-kinase mediated disorders |
| 08/08/2007 | EP1814550A2 N-sulfonylpiperidine cannabinoid receptor 1 antagonists |
| 08/08/2007 | EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 08/08/2007 | EP1631285B1 Therapeutic agents useful for treating pain |
| 08/08/2007 | EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors |
| 08/08/2007 | EP1585742B1 Substituted benzoyl derivatives uses as herbicides |
| 08/08/2007 | EP1546127B1 Novel pyrimidineamide derivatives and the use thereof |
| 08/08/2007 | EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/08/2007 | EP1351950B1 Isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders |
| 08/08/2007 | EP1343530B1 Oral pharmaceutical composition containing a block copolymer |
| 08/08/2007 | EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/08/2007 | EP1095037B2 process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl|sulfinyl-1h-benzimidazole |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/08/2007 | CN101014590A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 08/08/2007 | CN101014588A Pyrrole derivatives, their preparation and their therapeutic use |
| 08/08/2007 | CN101014587A Substituted biaryl piperazinyl-pyridine analogues |
| 08/08/2007 | CN101014578A 三唑衍生物或其盐 Triazole derivative or salt thereof |
| 08/08/2007 | CN101014576A Aryl spirolactam cgrp receptor antagonists |
| 08/08/2007 | CN101014575A Sigma receptor inhibitors |
| 08/08/2007 | CN101014574A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 08/08/2007 | CN101014573A 5-HT7 receptor antagonists |
| 08/08/2007 | CN101014570A Piperidine derivative or pharmaceutically acceptable salt thereof |
| 08/08/2007 | CN101012224A Quinoline derivative, preparation method and medical use thereof |
| 08/08/2007 | CN101012221A Antineoplastic alkaloid |
| 08/08/2007 | CN101012203A 1,2,4-triazol derivatives, method for preparing the same |
| 08/08/2007 | CN101012200A Process for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 08/08/2007 | CN101012193A Novel CB 1 receptour inverse agonists |
| 08/08/2007 | CN101012141A Method of manufacturing chiral sulfoxide compounds |
| 08/08/2007 | CN101011057A Process for the preparation of pesticide imidacloprid |
| 08/07/2007 | US7253290 3-[2,2-dimethyl-3-oxo-3-(7-azabicyclo[2.2.1]heptan-7-yl)propoxy]-4-[(1S)-1-methyl-2-[(isopropoxycarbonyl)imino(-3-pyridin-4-yl-pyrrolidin-1-yl)methyl]aminoethyl]-5-(3,5-dimethylphenyl)-1H-pyrazole; prodrugs for treating prostatic cancer, uterine cancer, breast cancer and pituitary gonadotrophe adenoma |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253205 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 08/07/2007 | US7253203 Indoline derivatives |
| 08/07/2007 | US7253200 Using in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease |
| 08/07/2007 | US7253197 2-aryl- or heteroarylamino- 5-cycloalkanoyl-, aroyl-, or heteroaroyl- thiazoles; treatment or prophylaxis of obesity, especially in combination with orlistat. |
| 08/07/2007 | US7253193 Pyridyl cyanoguanidine compounds, e.g., 1-[2-(4-Piperidyl)-ethoxy-carbonyloxymethyl]-4-[N'-cyano-N''-(6-(4-chloro-phenoxy)-1-hexyl)-N-guanidino]-pyridinium chloride, hydrochloride; human and veterinary therapy of proliferative diseases such as cancers |
| 08/07/2007 | US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/07/2007 | US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 08/07/2007 | US7253189 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 08/07/2007 | US7253188 Aminobenzamide derivative |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253186 N-substituted piperidine derivatives as serotonin receptor agents |
| 08/07/2007 | US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes |
| 08/07/2007 | US7253183 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253170 Pyrazole-amine compounds useful as kinase inhibitors |
| 08/07/2007 | US7253169 Aza compounds, pharmaceutical compositions and methods of use |
| 08/07/2007 | US7253164 1,4-benzothiazin-3-one derivatives that are optionally S-mono- or dioxygenated; peptide deformylase inhibitors, used for treating bacterial infections |
| 08/07/2007 | US7253157 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 08/07/2007 | US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors |
| 08/07/2007 | US7253007 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 08/07/2007 | US7252925 1-Alkoxy- or cycloalkoxy(poly)oxyethylenebenzimidazoles, e.g., 1-(2-methoxyethyl)-1H-benzimidazole, used to form amplified resists with excellent resolution, form precisely configured patterns with minimized roughness of sidewalls and useful in microfabrication using electron beams or deep-UV light. |
| 08/07/2007 | CA2302943C Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 08/07/2007 | CA2247734C New piperazine and piperidine compounds selectively binding dopamine and serotonin receptors |
| 08/07/2007 | CA2184842C New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 08/02/2007 | WO2007087488A2 Indole sulfonamide modulators of progesterone receptors |
| 08/02/2007 | WO2007087276A1 Aurora kinase modulators and method of use |
| 08/02/2007 | WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS |
| 08/02/2007 | WO2007087026A2 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 08/02/2007 | WO2007086799A1 Amide substituted quinolines |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086077A2 A novel one pot process for preparation of pantoprazole sodium sesquihydrate |
| 08/02/2007 | WO2007085750A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/02/2007 | WO2007085718A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof |
| 08/02/2007 | WO2007085565A1 Methods to use 3-pyridyl derivatives as pesticides |
| 08/02/2007 | WO2007085558A1 Use of 2-imidazoles for the treatment of cns disorders |
| 08/02/2007 | WO2007085540A1 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives |
| 08/02/2007 | WO2007085357A1 Cyclourea compounds as calcium channel blockers |
| 08/02/2007 | WO2007085205A1 Pyrrole substituted 2-indolinone derivatives, the preparation methods and medical uses thereof |
| 08/02/2007 | WO2007071753A3 S-omeprazole magnesium |
| 08/02/2007 | WO2007060408A3 L-phenylalanine derivatives and their use as integrin antagonists |
| 08/02/2007 | WO2007053131A3 Acrylamide derivatives as antibiotic agents |
| 08/02/2007 | WO2006127815A3 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 08/02/2007 | WO2006113304A3 Combinations, methods and compositions for treating cancer |
| 08/02/2007 | WO2006105442A3 Spirocyclic heterocyclic derivatives and methods of their use |
| 08/02/2007 | WO2006081391A3 Compounds for inflammation and immune-related uses |
| 08/02/2007 | WO2006073361A9 Novel pyridine compounds |
| 08/02/2007 | WO2006045096A3 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 08/02/2007 | WO2006037501A9 Alkil-pyridines as 11-beta inhibitors for diabetes |
| 08/02/2007 | US20070179298 Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179190 Vla-4 antagonists |
| 08/02/2007 | US20070179184 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists |